{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "TMB",
    "data": {
        "bs": [
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2458439
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1615980
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1615980
            },
            {
                "label": "Receivable from Reprise Biomedical, Inc.",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 9138
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 66770100
            },
            {
                "label": "Accrued royalties",
                "concept": "miro:AccruedRoyaltiesNoncurrent",
                "unit": "usd",
                "value": 734556
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 441582
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 3713491
            },
            {
                "label": "Common stock, par value $0.00001; 190,000,000 shares authorized; 20,024,552 issued and outstanding as of June 30, 2021 and 30,000,000 shares authorized; 2,185,822 issued and outstanding as of December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 200
            },
            {
                "label": "Lab equipment, furniture and leasehold improvements, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 351472
            },
            {
                "label": "Lab equipment, furniture and leasehold improvements, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 351472
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 126926215
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 66525757
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -63518334
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 67121572
            },
            {
                "label": "Grant receivable",
                "concept": "GrantsReceivableCurrent",
                "unit": "usd",
                "value": 120000
            },
            {
                "label": "Current portion of long-term debt",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 400341
            },
            {
                "label": "Current portion of long-term debt",
                "concept": "LongTermDebtAndCapitalLeaseObligationsCurrent",
                "unit": "usd",
                "value": 400341
            },
            {
                "label": "Total shareholders' equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 63408081
            },
            {
                "label": "Total shareholders' equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 63408081
            },
            {
                "label": "Total shareholders' equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 63408081
            },
            {
                "label": "Accrued interest",
                "concept": "miro:InterestPayableNoncurrent",
                "unit": "usd",
                "value": 58472
            },
            {
                "label": "Accrued interest expense",
                "concept": "InterestPayableCurrent",
                "unit": "usd",
                "value": 536
            },
            {
                "label": "Total Liabilities, Mezzanine Equity and Shareholders' Equity (Deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 67121572
            },
            {
                "label": "Long-term debt, less current portion",
                "concept": "LongTermDebtAndCapitalLeaseObligations",
                "unit": "usd",
                "value": 462024
            },
            {
                "label": "Long-term debt, less current portion",
                "concept": "LongTermDebtAndCapitalLeaseObligations",
                "unit": "usd",
                "value": 462024
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 115205
            }
        ],
        "cf": [
            {
                "label": "Purchases of lab equipment, furniture and leasehold improvements",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 86112
            },
            {
                "label": "Change in fair value of derivative",
                "concept": "EmbeddedDerivativeGainOnEmbeddedDerivative",
                "unit": "usd",
                "value": 246962
            },
            {
                "label": "Change in fair value of derivative",
                "concept": "EmbeddedDerivativeGainOnEmbeddedDerivative",
                "unit": "usd",
                "value": 246962
            },
            {
                "label": "Prepaid expenses",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": -15371
            },
            {
                "label": "Proceeds from sale of preferred stock, net",
                "concept": "miro:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStockNet",
                "unit": "usd",
                "value": 19891670
            },
            {
                "label": "Amortization of discount on note",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 62638
            },
            {
                "label": "Forgiveness of paycheck protection program loan",
                "concept": "miro:GainOnForgivenessOfDebt",
                "unit": "usd",
                "value": 518050
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 8768
            },
            {
                "label": "Increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 62081362
            },
            {
                "label": "Accrued interest",
                "concept": "miro:IncreaseDecreaseInInterestPayableNoncurrent",
                "unit": "usd",
                "value": 581799
            },
            {
                "label": "Proceeds from stock options exercise",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 34625
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 327276
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 239330
            },
            {
                "label": "Proceeds from stock warrants exercise",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 6250
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -5390815
            },
            {
                "label": "Payments on long-term debt",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 53367
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -4137176
            },
            {
                "label": "Proceeds from sale of common stock, net",
                "concept": "miro:ProceedsFromIssuanceOfCommonStockNet",
                "unit": "usd",
                "value": 45679111
            },
            {
                "label": "Accrued expenses related to financing",
                "concept": "miro:NoncashInvestingAndFinancingFinancingExpenses",
                "unit": "usd",
                "value": 1085425
            },
            {
                "label": "Net cash provided by (used in) investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 1913888
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 65558289
            },
            {
                "label": "Gain on sale of equity investment",
                "concept": "EquitySecuritiesFvNiRealizedGainLoss",
                "unit": "usd",
                "value": 1983912
            },
            {
                "label": "Gain on sale of equity investment",
                "concept": "EquitySecuritiesFvNiRealizedGainLoss",
                "unit": "usd",
                "value": 1983912
            },
            {
                "label": "Grant receivable",
                "concept": "miro:IncreaseDecreaseInGrantsReceivable",
                "unit": "usd",
                "value": -20000
            },
            {
                "label": "Receivable from Reprise Biomedical, Inc",
                "concept": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": -6064
            },
            {
                "label": "Depreciation and amortization expense",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 59174
            },
            {
                "label": "Depreciation and amortization expense",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 59174
            },
            {
                "label": "Equity loss in affiliate",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -223633
            },
            {
                "label": "Equity loss in affiliate",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -223633
            },
            {
                "label": "Proceeds from sale of equity method investment shares",
                "concept": "ProceedsFromSaleOfEquityMethodInvestments",
                "unit": "usd",
                "value": 2000000
            }
        ],
        "ic": [
            {
                "label": "Loss from continuing operations",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -6415505
            },
            {
                "label": "Net loss per share, basic (in dollar per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.6
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 6057089
            },
            {
                "label": "Cost of goods sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Research and development expenses",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 4348888
            },
            {
                "label": "Amortization of discount on note",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 62638
            },
            {
                "label": "Regulatory and clinical",
                "concept": "miro:RegulatoryAndClinicalExpense",
                "unit": "usd",
                "value": 186961
            },
            {
                "label": "Research grants",
                "concept": "miro:ResearchGrants",
                "unit": "usd",
                "value": 277965
            },
            {
                "label": "Operating loss from continuing operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -6291842
            },
            {
                "label": "Equity loss in affiliate",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -223633
            },
            {
                "label": "Equity loss in affiliate",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -223633
            },
            {
                "label": "Weighted average shares used in computing net loss per share, diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 2586477
            },
            {
                "label": "Licensing revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 15247
            },
            {
                "label": "Gain on sale of equity investment",
                "concept": "EquitySecuritiesFvNiRealizedGainLoss",
                "unit": "usd",
                "value": 1983912
            },
            {
                "label": "Gain on sale of equity investment",
                "concept": "EquitySecuritiesFvNiRealizedGainLoss",
                "unit": "usd",
                "value": 1983912
            },
            {
                "label": "General & administration",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1349196
            },
            {
                "label": "Gain on debt extinguishment",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": 518050
            },
            {
                "label": "Gross margin",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": -234753
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 85
            },
            {
                "label": "Weighted average shares used in computing net loss per share, basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 2586477
            },
            {
                "label": "Net loss per share, diluted (in dollar per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.6
            },
            {
                "label": "Change in fair value of derivative",
                "concept": "EmbeddedDerivativeGainOnEmbeddedDerivative",
                "unit": "usd",
                "value": 246962
            },
            {
                "label": "Change in fair value of derivative",
                "concept": "EmbeddedDerivativeGainOnEmbeddedDerivative",
                "unit": "usd",
                "value": 246962
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -4137176
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -4137176
            },
            {
                "label": "Quality",
                "concept": "miro:QualityExpense",
                "unit": "usd",
                "value": 172044
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpenseDebtExcludingAmortization",
                "unit": "usd",
                "value": 586037
            }
        ]
    }
}